Skip to search formSkip to main contentSkip to account menu

Fibrinolytic Agents

Known as: thrombolytic drug, [BL115] THROMBOLYTICS, Thrombolytic Drugs 
Any agent capable of dissolving an existing blood clot in order to reperfuse the blocked blood vessel.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
2008;133;113-122 Chest Holger J. Schünemann, Deborah Cook and Gordon Guyatt Guidelines (8th Edition) Physicians Evidence-Based… 
Highly Cited
2008
Highly Cited
2008
This chapter about treatment for venous thromboembolic disease is part of the American College of Chest Physicians Evidence-Based… 
Highly Cited
2005
Highly Cited
2005
BACKGROUND A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment… 
Review
2004
Review
2004
This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND The relative efficacy of streptokinase and tissue plasminogen activator and the roles of intravenous as compared with… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND The success of thrombolytic therapy for acute myocardial infarction is limited by bleeding complications, the… 
Highly Cited
1987
Highly Cited
1987
Intravenous administration of 80 mg of recombinant tissue plasminogen activator (rt-PA, 40, 20, and 20 mg in successive hours…